Meat-Tech 3D Return on Tangible Equity 2010-2012 | MTTCF
Current and historical return on tangible equity values for Meat-Tech 3D (MTTCF) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Meat-Tech 3D Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2012-09-30 |
$0.00B |
$0.00B |
-400.00% |
| 2012-06-30 |
$0.00B |
$0.00B |
100.00% |
| 2012-03-31 |
$0.00B |
$0.00B |
-150.00% |
| 2011-12-31 |
$-0.01B |
$0.00B |
-228.57% |
| 2011-09-30 |
$0.00B |
$0.00B |
-16.67% |
| 2011-06-30 |
$0.00B |
$0.01B |
-11.76% |
| 2011-03-31 |
$0.00B |
$0.01B |
11.11% |
| 2010-12-31 |
$0.01B |
$0.01B |
124.14% |
| 2010-09-30 |
$0.00B |
$0.01B |
63.16% |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Food Items - Meat Products |
$0.000B |
$0.000B |
|
D. Medical Industries Ltd. is a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of products for diabetes treatment and drug delivery. Through its subsidiary NextGen Biomed Ltd., it also invests in select medical device opportunities. The Company's products include ADI Insulin pump and Lighty DD infusion set. ADI is an insulin delivery system, utilizing spring technology. A spring compressed when insulin is loaded creates internal pressure that controls the flow of a measured amount of insulin through the system. The Lighty DD infusion set is a novel infusion set designed to quickly identify situations in which the cannula of the infusion set is separated from the body. Lighty DD uses blocking mechanism that is integrated into the base of the infusion set. If the base is detached from the body, insulin flow is stopped and a pump alarm is sounded. D. Medical is also developing a continuous glucose monitor. The Company is based in Tirat Carmel, Israel.
|
